These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3013800

  • 1. Therapeutic trials of multiple sclerosis and intrathecal IgG production.
    Wender M, Tokarz E, Michalowska G, Wajgt A.
    Ital J Neurol Sci; 1986 Apr; 7(2):205-8. PubMed ID: 3013800
    [Abstract] [Full Text] [Related]

  • 2. Multiple sclerosis de novo CNS IgG synthesis. Effect of CNS irradiation.
    Tourtellotte WW, Potvin AR, Baumhefner RW, Potvin JH, Ma BI, Syndulko K, Petrovich Z.
    Arch Neurol; 1980 Oct; 37(10):620-4. PubMed ID: 6252876
    [Abstract] [Full Text] [Related]

  • 3. [Effect of ACTH therapy on IgG synthesis in cerebrospinal fluid spaces in patients with disseminated sclerosis].
    Wender M, Michałowska G, Wajgt A.
    Neurol Neurochir Pol; 1986 Oct; 20(5):437-43. PubMed ID: 3035406
    [Abstract] [Full Text] [Related]

  • 4. Schemes to eradicate the multiple sclerosis central nervous system immune reaction.
    Tourtellotte WW, Murthy K, Brandes D, Sajben N, Ma B, Comiso P, Potvin A, Costanza A, Korelitz J.
    Neurology; 1976 Jun; 26(6 PT 2):59-61. PubMed ID: 179031
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of immunosuppressive therapy on humoral immune response in multiple sclerosis.
    Wajgt A, Górny M, Szczechowski L, Grzybowski G, Ochudło S.
    Acta Med Pol; 1989 Jun; 30(3-4):121-8. PubMed ID: 2485126
    [Abstract] [Full Text] [Related]

  • 10. Multiple sclerosis de novo CNS IgG synthesis: effect of ACTH and corticosteroids.
    Tourtellotte WW, Baumhefner RW, Potvin AR, Ma BI, Potvin JH, Mendez M, Syndulko K.
    Neurology; 1980 Nov; 30(11):1155-62. PubMed ID: 6252511
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of alternating treatment of multiple sclerosis with encorton and levamisole on IgG synthesis within the cerebrospinal fluid spaces].
    Wender M, Michałowska G, Tokarz-Kupczyk E.
    Neurol Neurochir Pol; 1988 Nov; 22(2):103-7. PubMed ID: 3405385
    [Abstract] [Full Text] [Related]

  • 14. The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.
    Lamers KJ, Uitdehaag BM, Hommes OR, Doesburg W, Wevers RA, von Geel WJ.
    J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1334-7. PubMed ID: 2465387
    [Abstract] [Full Text] [Related]

  • 15. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.
    Staugaitis SM, Shapshak P, Myers LW, Ellison GW, Tourtellotte WW, Lee M.
    Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418
    [Abstract] [Full Text] [Related]

  • 16. Oligoclonal and polyclonal synthesis of IgG in the central nervous system: an isoelectric focusing study.
    Arata L, Leonardi A.
    Clin Immunol Immunopathol; 1988 Apr; 47(1):10-8. PubMed ID: 3349654
    [Abstract] [Full Text] [Related]

  • 17. Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
    Hommes OR, Prick JJ, Lamers KJ.
    Clin Neurol Neurosurg; 1975 Apr; 78(1):59-72. PubMed ID: 1157430
    [Abstract] [Full Text] [Related]

  • 18. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.
    Link H, Tibbling G.
    Scand J Clin Lab Invest; 1977 Sep; 37(5):397-401. PubMed ID: 337461
    [Abstract] [Full Text] [Related]

  • 19. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
    Durelli L, Cocito D, Riccio A, Barile C, Bergamasco B, Baggio GF, Perla F, Delsedime M, Gusmaroli G, Bergamini L.
    Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
    [Abstract] [Full Text] [Related]

  • 20. Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans.
    Wolkowitz OM, Papadopoulos NM, Costello R, Breier A, Doran AR, Pickar D, Rubinow D.
    Psychoneuroendocrinology; 1990 Feb; 15(2):155-8. PubMed ID: 2359811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.